Table 1.
Preoperative characteristics of the patients considered in the study.
| HoLEP (n = 117) | ThuLEP (n = 117) | p value | ||
|---|---|---|---|---|
| Age, years (range) | 71 (66–75) | 70 (65–75) | 0.587 | |
| Age in classes | <60 years, n (%) | 10 (8.6) | 9 (7.8) | 0.745 |
| 60–70 years, n (%) | 45 (38.8) | 50 (43.1) | 0.468 | |
| >70 yrs, n (%) | 61 (52.6) | 57 (49.1) | 0.602 | |
| ASA score | 2 (1–2) | 2 (1–2) | 0.430 | |
| ASA score in classes, n (%) | 1 + 2 | 103 (88) | 103 (88) | 0.392 |
| 3 | 14 (12) | 14 (12) | 0.500 | |
| Prostatic volume, ml (range) | 75 (60–100) | 75 (60–95) | 0.715 | |
| Prostatic volume in classes, ml (%) | <60 | 37 (31.6) | 40 (34.2) | 0.676 |
| 60–80 | 32 (27.4) | 29 (24.8) | 0.655 | |
| 80–100 | 27 (23.1) | 28 (23.9) | 0.877 | |
| 100–120 | 13 (11.1) | 10 (8.5) | 0.510 | |
| >120 | 8 (6.8) | 10 (8.5) | 0.623 | |
| Indwelling catheterization n (%) | 31 (26.7) | 47 (40.5) | 0.026 | |
| IPSS (range) | 21 (17.5–25.5) | 20 (18.25–24) | 0.548 | |
| QoL (range) | 5 (4–5) | 5 (5–6) | 0.492 | |
| PSA ng/ml (range) | 5.48 (3.135–8.4) | 3.8 (2.92–5.5) | 0.463 | |
| Qmax ml/s (range) | 7 (5.0–9.4) | 7 (6–9) | 0.172 | |
| PVR ml(range) | 103.5 (58.5–200) | 90 (20–100) | 0.135 | |
| Preoperative Hb (range) | 14.05 (13.6–15.3) | 13.5 (12.5–14.1) | 0.086 | |
Bold numbers represent statistical significance. Values are expressed in median (interquartile range, IQR) or in percentage. Quantitative variables are compared with the Wilcoxon test and qualitative variables with the McNemar test (for two variables) or Cochran Q test (for more than two variables). ASA score, American Society of Anesthesiologists classification; Hb, hemoglobin; IPSS, International Prostate Symptom Score; PSA, prostate-specific antigen; PVR, postvoid residual urine; Qmax, maximum urinary flow rate; QoL, Quality of Life Index.